Breaking News Bar

Business News and Information

Mighty mighty prostones: How Peter Greenleaf is reshaping Sucampo

Four months into his tenure as CEO of Sucampo Pharmaceuticals Inc., former MedImmune president Peter Greenleaf emerged this week with a new blueprint for the Bethesda drug-maker...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear